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Depression in adolescents if unrecognized, can interfere with every aspect of the
individual’s life, increasing the risk for illness and interpersonal difficulties in the future.
Therefore, it is imperative that significant levels of depressive symptoms be recognized,
assessed, and treated. The usefulness and psychometric properties of new measures of depression
are determined, in part, through comparison with existing measures. The current study
investigated the concurrent validity of the Clinical Assessment of Depression (CAD; Bracken &
Howell, 2004) with the Beck Depression Inventory-Second Edition (BDI-II; Beck, Steer, &
Brown, 1996) for an adolescent population. The sample for this investigation consisted of 23
adolescents (13-18 years) with a primary diagnosis of unipolar depression and 98 adolescents
that did not have a clinical diagnosis. Correlation coefficients were large and statistically
significant between the CAD and BDI-II, ranging from .97 to .66. The CAD was able to
distinguish between clinical and non-referred groups on the basis of mean group scores. Using
the BDI-II classification as the criterion, a contingency table was computed and a classification
consistency of 82% for the total sample was found. Findings of the current study indicate that the
CAD appears to have adequate validity to support its use with adolescents.
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Review of the Literature
Depression is prevalent in the adolescent population and is often overlooked (Fritz, 1997;
Peterson et al., 1993). It is important that depression be recognized, assessed, and treated in
adolescents to reduce its impact on an individual’s life, increasing the risk of illness and
interpersonal difficulties in the future. Self-report measures are often used for assessing
depression in adolescents. It is important that the self-report measures used have evidence of
adequate psychometric properties, including adequate validity. The present investigation will
explore the concurrent validity of a newly developed measure of depression with an established
measure.
The next section will provide a review of literature relevant to the current investigation of
the validity of the Clinical Assessment of Depression (CAD; Bracken & Howell, 2004). First, an
overview of child and adolescent depression will be provided including incidence,
symptomology, and diagnostic criteria. Next, the assessment of depression in children and
adolescents will be reviewed. Last, the purpose of the present investigation will be presented.
Depression in Adolescents
Depression is a psychological disorder that is often overlooked among child and
adolescent populations. According to Reynolds (1992), 8 to 18% of school-aged youth have
experienced a clinical level of depression. Health care providers and family members of children
and adolescents often view possible indicators of depression expressed by young people as
typical mood swings and, as a result, the disorder remains under-diagnosed and untreated
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(Evans, Velsor, & Schumacher, 2002; National Institute of Mental Health [NIMH], 2000).
Children and adolescents often display classic symptoms such as low self-esteem, guilt, loss of
interest in school activities, decreased school performance, and boredom, yet find these emotions
difficult to identify or label in themselves (NIMH, 2000). It is critical for the depressive
symptoms of adolescents to be recognized, evaluated, and treated, as depression can increase the
risk for illness and interpersonal difficulties in the future and affects almost every aspect of that
individual’s life (Evans et al., 2002; Stanard, 2000).
Research concerning childhood and adolescent depression has increased over the past
two decades and a knowledge base regarding childhood depression has emerged. Prevalence
rates for major depression are comparable to that of adults, making depression a major health
problem among this population. The incidence of depression among youth in the United States
ages 9-17 is estimated to be around 5%, with 1.5% to 4.7% being diagnosed with Major
Depressive Disorder (Fritz, 1997; Pullen, Modrcin-McCarthy, & Graf, 2000; Stanard, 2000).
The prevalence of depressive disorders differs in countries throughout the world. Past
research indicates percentages ranging from 11.7% of adolescents in East Germany to 40% of
Bulgarian adolescents. In the United States, Canada, and Britain, the prevalence was found to be
around 10% and in Poland, the percentage was around 30 (Boyd, Gullone, Kostanski, Ollendick,
& Shek, 2000). While prevalence rates may vary across countries, depression appears to be a
universal construct of significant concern in children and adolescents.
Gender and depression. When looking at the prevalence rates of depression by gender,
an equal number of boys and girls suffer from depression prior to adolescence. The percentage of
adolescent boys identified as experiencing a depressed mood is between 20 and 35% while for
adolescent girls, the percentage rate is between 25 and 40 % (Peterson et al., 1993).
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During adolescence, however, rates of unipolar depression (major depressive disorder,
dysthymic disorder, or depressive disorder not otherwise specified) have been found to be higher
for girls than for boys (Baron & Campbell, 1993; Herson & Ammerman, 2000; Marcotte, Fortin,
Potvin, & Papillon, 2002; Rutter, Graham, Chadwick, & Yule, 1976). In a study comparing
female and male mean scores on the Reynolds Adolescent Depression Scale (RADS) and the
Beck Depression Inventory (BDI), Baron and Campbell (1993) examined whether females
exhibit higher mean scores on discriminating items than males. It was found that females do in
fact have higher mean scores on these items. This supports the view that females
characteristically report more depressive symptoms than males.
Diagnostic criteria. In determining a diagnosis of depression for adolescents, the criteria
set forth by the Diagnostic and Statistical Manual of Mental Disorders-4th Edition Text Revision
(DSM-IV-TR; American Psychiatric Association [APA], 2000) must be met. The DSM-IV-TR
consists of three diagnostic categories for unipolar depressive disorders. Of importance to this
investigation are the criteria for the unipolar types of depression: major depressive disorder,
dysthymic disorder, and depressive disorder not otherwise specified.
As a severe form of depression, Major Depressive Disorder is characterized by one or
more Major Depressive Episodes. These episodes last at least two weeks and consist of
depressed mood and loss of interest in most all activities. The individual must also suffer from at
least four of the following symptoms: “changes in appetite or weight, sleep, and psychomotor
activity; decreased energy; feelings of worthlessness or guilt; difficulty thinking, concentrating,
or making decisions; or recurrent thoughts of death or suicidal ideation, plans or attempts” (APA,
2000, p. 356).
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The second depressive diagnostic category is Dysthymic Disorder. This form of
depression consists of a less severe symptom pattern than major depression; however, the
symptoms are chronic in that two or more symptoms are experienced for at least one year. With
children and adolescents, symptoms must last at least one year and may include: irritability, poor
self-esteem, poor social skills, feelings of hopelessness, and impaired school performance (APA,
2000).
The third diagnostic category involving unipolar depression in the DSM-IV-TR is
Depressive Disorder Not Otherwise Specified. This form of depression includes depressive
features consistent with that required to diagnose major depression or dysthymia, yet the
symptom pattern does not meet the criteria for any other Depressive Disorders in severity,
quantity, or duration. When there is inadequate or contradictory information, this form of
depression may be used for diagnosis (APA, 2000).
Adolescent symptoms. While the same criteria are required for a diagnosis of Major
Depressive Disorder in adolescents as in adults, the symptoms are commonly presented
differently (Mash & Wolfe, 2002; Mellin & Beamish, 2002; Oster & Montgomery, 1994;
Stanard, 2000). Adolescents experiencing depressive disorders tend to exhibit more
helplessness, fatigue, despair, lack of pleasure, suicidal thoughts, hypersomnia, and variations in
weight than depressed adults (Reynolds, 1990; Wright-Strawderman, Lindsey, Navarrete, &
Flippo, 1996). Depressive disorders during adolescence also tend to be more episodic, with
phases of depression, followed by phases of better functioning (Fritz, 1997; Mash & Wolfe,
2002). Impairments in academic performances and relationships with others is often noted in
adolescents experiencing clinical levels of depression (Evans et al., 2002; Mellin & Beamish,
2002). Adolescent depression may also be expressed in ways that do not even resemble
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depressive symptoms, such as behavior problems, family problems, substance abuse, or rebellion
(Mellin & Beamish, 2002). There are also gender differences in the expression of depressive
symptoms. Males tend to exhibit more irritability, work inhibition, sleep disturbance, and social
withdrawal while females tend to exhibit more body image distortion, loss of appetite, sadness,
dissatisfaction, and weight loss (Baron & Campbell, 1993).
Assessment of Depression
Use of self-report measures. The diagnosis of depression is reached after a
comprehensive assessment in which information about the individual’s symptoms and
behavior/behavior patterns are obtained. Recommended practices in diagnosis are to gain such
information primarily through a multimodal assessment approach utilizing clinical/diagnostic
interviews with the child/adolescent or their parent(s), documentation of the child’s/adolescent's
behavior over time through use of behavior checklists, and self-report measures (WrightStrawderman et al., 1996). While all of these methods are important to use in a thorough
assessment, self-report measures are frequently utilized to assess depression and are the focus for
this investigation (Martin, 1988; Reynolds, 1990; Shinn, Walker, & Stoner, 2002; Stanard, 2000;
Wright-Strawderman et.al., 1996).
Self-report measures are frequently used in social-emotional assessment (Marcotte et al.,
2002; Stanard, 2000; Reynolds, 1990; Wright-Strawderman et al., 1996). The utilization of such
measures enables individuals to report their own internal thoughts, feelings, and emotions. This
allows for better first-hand information of an individual's internal experience of depression than
what could be obtained from a third party’s observation of symptom patterns.
Objective self-report measures are standardized instruments. They require the
completion of questions or items concerning an individual's own social or emotional behavior
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and answers are compared to a population sample. It has been proposed by Martin (1988) that
self-report measures must have four essential characteristics present before being considered for
use: (a) adequate test-retest reliability, (b) standardized procedures, (c) normative data for
comparison, and (d) adequate validity.
Types of self report rating scales. Self-report measures vary on the scope of the
behaviors or symptomology covered. There are some self-report measures available that deal
with a broad range of symptomology; however, there are also measures available that focus only
on depression symptomology. Such standardized measures that assess adolescent depression
include the Beck Depression Inventory-II (BDI-II; Beck, Steer, & Brown, 1996) and the
Reynolds Adolescent Depression Scale (RADS; Reynolds, 1987). While some measures are
helpful as a screener to provide information regarding depressive symptoms, the RADS and the
BDI-II provide a more systematic depth of coverage into depressive symptoms.
The Beck Depression Inventory-II (BDI-II) was developed by Beck, Steer, and Brown
(1996). The BDI-II replaced the original BDI (Beck, Ward, Mendelson, Mock, & Erbaugh,
1961) and modernized the amended Beck Depression Inventory (BDI-IA; Beck, Rush, Shaw, &
Emery, 1979). The BDI, and later the BDI-IA, have been the most widely used measures in
assessing the severity of depression in psychiatric patients, as well as detecting depression in
normal populations (Archer, Maruish, Imhof, & Piotrowski, 1991; Piotrowski & Keller, 1992;
Piotrowski, Sherry, & Keller, 1985). The current edition of the BDI, the BDI-II, assesses the
severity of depressive symptoms in adults and adolescents, ages 13 to 80. It measures
symptoms related to the cognitive, affective, behavioral, and somatic components of depression
through responses to 21 items. A total score provides an estimate of the overall severity of
depression.
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In modernizing the amended Beck Depression Inventory, the revised BDI-II replaced
items of Weight Loss, Body Image Change, Somatic Preoccupation, and Work Difficulty with
Agitation, Worthlessness, Concentration Difficulty, and Loss of Energy. To allow for increases
and decreases in appetite, two items were changed and many statements used in rating other
symptoms were reworded. The BDI-II stands as a major revision of the BDI, more so than the
BDI-IA, and was developed to be more consistent with DSM-IV criteria.
The psychometric properties of the BDI-II are quite strong. The BDI-II has good
reliability and validity and has been shown to discriminate between individuals with depression
and those without depression (Beck, Steer, & Brown, 1996; Krefetz, Steer, Gulab, & Beck,
2002; Plake & Impara, 2001). The BDI-II has shown to be a useful tool in assessing depression
and it is widely used within the field of psychology (Camara, Nathan, & Puente, 2000; Plake &
Impara, 2002; Wilcox, Field, Prodromidis, & Scafidi, 1998).
As mentioned previously, Martin’s (1988) criteria described four essential characteristics
that a self-report measure should possess in order to be considered a good self-report measure.
The BDI-II has established test-retest reliability of .93 (Beck et al., 1996; Plake & Impara, 2001).
Standardization procedures are utilized in the BDI-II in that test items are presented in a
consistent manner, and the responses are compared to responses of other individuals. The BDI-II
provides normative data that allow a score to be compared to a larger group of individuals, and it
has established validity (Beck, Steer, & Brown, 1996; Krefetz et al., 2002; Plake & Impara,
2001). Based on Martin’s criteria, the BDI-II is an established self-report measure that provides
reliable, standardized, valid information to the professionals that utilize it.
The Clinical Assessment of Depression (CAD; Bracken & Howell, 2004) is an
instrument that is under development by Psychological Assessment Resources (PAR). It was
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developed to answer the question of whether or not depressive symptoms are consistent across
the age range from childhood through adulthood. The existing published measures are designed
either for adult or child populations. The CAD assesses depression among children, adolescents,
and adults using a single form. Because the CAD is currently under development, there is limited
information available. However, preliminary information indicates that this measure has
adequate test-retest reliability and validity (B. A. Bracken, personal communication, March 25,
2004).
Purpose of Present Investigation
Self-report measures play an important role in the assessment of depression. Due to the
internalizing nature of depression, an individual is more in tune to their own thoughts and
feelings than what a third party can ascertain through observation (Merrell, 1999; Reynolds,
1990; Stanard, 2000). Since individuals are more credible sources of their own depressive
symptoms, self-report measures are often used within the field of psychology. Further, the BDIII is one of the most frequently used measures in clinical psychology. In a survey conducted by
Camara, Nathan, and Puente (2000), current uses of psychological assessment measures by
clinical psychologists and neuropsychologists were investigated. A rank-order list of the top 20
tests used within the participants’ profession resulted in a BDI-II ranking of 10. Regarding the
most often used personality measures, the BDI-II ranked second (Camara et al., 2000). Thus, the
BDI-II is a well-known and frequently used assessment tool for psychologists.
In order to validate the usefulness and psychometric properties of new measures, existing
measures are one criterion by which to judge new instruments. According to the Standards for
Educational and Psychological Testing (AERA, APA, & NCME, 1999), such investigations
should be conducted prior to the instrument’s use in the field. The purpose of this investigation
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is to examine the concurrent validity of a measure under development, the Clinical Assessment
of Depression (CAD), with an existing proven measure, the Beck Depression Inventory- Second
Edition (BDI-II). The hypotheses for this investigation are as follows.
1. The CAD total score and subscales will evidence strong concurrent validity with the
BDI-II total score for the total sample. Concurrent validity will be evidenced by total
scores yielding statistically significant, moderate to high correlations.
2. The clinical group will evidence significantly higher mean scores on the CAD than
the non-referred group and higher group mean scores on the BDI-II than the nonreferred group.
In addition to the above hypotheses, the classification efficacy of the CAD was examined
using the BDI-II as the criterion measure.

Method
Participants
The total sample consisted of 65 female and 56 male adolescents ages 13 to18. The mean
age for the total sample was 15 years of age. The ethnicity of the total sample consisted of 111
Caucasians, 9 African Americans, and 1 Other. The clinical sample comprised of 23 participants,
13 females and 10 males, with a mean age of 15.0 years old. Among this group were 21 (91.3%)
Caucasian and 2 (8.7%) African American participants. These participants had a clinician
confirmed primary or secondary diagnosis of Major Depressive Disorder, Dysthymia, or
Depressive Not Otherwise Specified (NOS), as based on DSM-IV-TR (APA, 2000) criteria.
Participants for the clinical sample were allowed to have a dual diagnosis, as long as the
additional diagnosis was not a diagnosis with a psychosis (e.g., Bi-Polar Disorder,
Schizophrenia). The clinical participants were recruited through inpatient and outpatient
facilities, as well as private practice clinicians’ offices. Comprising the clinical sample were 14
adolescents with a primary diagnosis of Depressive Disorder NOS, 2 with Dysthymic Disorder, 1
with Cyclothymic Disorder, 5 with Major Depression, and 1 with a secondary diagnosis of Major
Depression. Of the clinical participants, 10 (44%) were not taking psychotropic medications.
The non-referred sample consisted of 98 participants, 52 females and 46 males, recruited
from a high school in south-central Kentucky. The mean age for the non-referred group was 15.4
(SD=1.14) years old and this group included 92 (92%) Caucasians, 7 (7%) African Americans,
and 1 (1%) Other. The participants were self-reported to have no existing diagnosis of Major
Depression, Dysthymia, or Depressive NOS, as based on DSM-IV-TR (APA, 2000) criteria.
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Instruments
Beck Depression Inventory-Second Edition (BDI-II). The Beck Depression Inventory
Second Edition (Beck, Steer, & Brown, 1996) is one of the most widely used self-report
measures of depression (Camara et al., 2000; Plake & Impara, 2001; Wilcox et al.,1998). The
high usage of the BDI-II is a continuation of the original BDI and BDI-IA. As a revision of the
BDI-IA and original BDI, the BDI-II is a 21-item, self-report instrument that can be used with
ages 13 to 80. The BDI-II can be used as an indicator of the presence and degree of depressive
symptoms.
The BDI-II assesses symptoms of depression that correspond to criteria in the Diagnostic
and Statistical Manual of Mental Disorders-Fourth Edition for diagnosing depressive disorders
(APA, 2000). The BDI-II takes approximately 5 to 10 minutes to complete, and can be
administered orally if needed. Items are rated on a 4-point scale, ranging from 0-3. In scoring
the BDI-II, ratings are summed to derive a total score. The maximum total score is 63.
“Minimal” depression is represented by total scores of 0 to 13, “Mild” depression by total scores
of 14 to 19, “Moderate” depression by total scores of 20 to 28, and total scores of 29 to 63 as
“Severe” depression (Beck, Steer, & Brown, 1996). For this study, a cutoff score of 17 for
depression was used, which is recommended by the manual.
The psychometric properties of the BDI-II and its previous editions have been
investigated for many years to support the use of the instrument with clinical and non-clinical
populations. The BDI-II is the 1996 revision of the amended BDI-IA and the original BDI. The
BDI-II has not been independently studied as extensively as the previous editions. However, the
BDI-II adds to the 35 years of psychometric data collected on the BDI and BDI-IA. Therefore,
psychometric data regarding the original BDI and/or BDI-IA may also be reported.
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In reviewing 25 years of evaluation of the original BDI, Beck, Steer, and Garbin (1988),
reported that the internal consistency of the BDI yielded coefficient alphas from .76 to .95, with
a mean coefficient alpha of .86 for psychiatric populations. For nonpsychiatric samples, a mean
alpha of .81 was determined, with the range being .73 to .92. Strober, Green, and Carlson (1981)
found a coefficient alpha estimate of internal reliability of .79 among 78 adolescent inpatients on
the BDI.
A study by Beck, Steer, & Brown (1996) investigated the psychometric properties of the
BDI-II. A coefficient alpha internal consistency reliability of .92 was reported with an outpatient
group, and .93 for the college students. Of the 21 items on the BDI-II, corrected item-total
correlations for the outpatient and college student samples were significant and ranged from
correlations from .39 to .70 for the outpatient sample. The college student sample correlations
ranged from .27 to .74 (Beck, Steer, & Brown, 1996).
In another investigation, a coefficient alpha of .89 for the BDI-II was obtained for college
students, indicating a high internal consistency (Steer & Clark, 1997). Additionally, a study
conducted by Beck, Steer, Ball, and Ranieri (1996) found internal consistencies of .91 for the
BDI-II and a .89 for the BDI-IA, indicating that the internal consistency of the BDI-II is
comparable to that of the BDI-IA.
Based on responses of a subsample of 26 outpatients, the BDI-II test-retest correlation
was .93 (Beck et al., 1996). Strober et al. (1981) determined a test-retest correlation of .74
among adolescents diagnosed with Major Depression, and .69 for adolescents with nonaffective
diagnoses.
Convergent and discriminant validity of the BDI-II are evidenced through correlations
with other psychological tests assessing similar constructs including: the Hamilton Psychiatric
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Rating Scale for Depression (HRSD), Beck Hopelessness Scale (BHS), Scale for Suicide
Ideation (SSI), Beck Anxiety Inventory (BAI), and the Revised Hamilton Anxiety Rating Scale
(HARS-R). The total test correlation between the BDI-II and the Beck Hopelessness Scale
(BHS) was .68 and a correlation between the BDI-II and the Scale for Suicide Ideation (SSI) was
.37. The BHS and SSI evidence divergent validity. The correlation between the BDI-II and the
Beck Anxiety Inventory (BAI) was .60. The BDI-II scores were most highly correlated with the
Hamilton Rating Scale for Depression (HRSD) with a correlation of .71 (Beck, Steer, & Brown,
1996: Krefetz et al., 2002; Plake & Impara, 2001). Thus the BDI-II evidences convergent and
divergent validity.
Krefetz et al. (2002) investigated the convergent validity of the BDI-II with the Reynolds
Adolescent Depression Scale (RADS; Reynolds, 1987). The findings indicated similar
psychometric properties between the BDI-II and RADS with coefficient alpha internal
consistency reliability greater than .90. These internal consistencies of the BDI-II and RADS
were found to be excellent for clinical purposes according to Cicchetti’s (1994) guidelines.
Inpatient adolescents diagnosed with Major Depressive Disorder indicated more severe
depression than those who were not diagnosed with Major Depressive Disorder. Additionally,
results support BDI-II convergent validity for assessing depression in adolescent inpatients
through self-report. A correlation between the BDI-II and the RADS was found to be positive
and strong (r = .84).
The review of the BDI-II provides support for its usefulness in assessing adolescent
depression. As an established measure, the BDI-II has strong psychometric properties. The BDIII appears to be good and plausible measure in indicating the presence and degree of depressive
symptoms.
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Clinical Assessment of Depression (CAD). The Clinical Assessment of Depression
(CAD) is currently in development by Psychological Assessment Resources. It is a 50-item
scale that takes approximately 10 minutes to complete. The CAD has four subscales, which are:
Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue. The
age range for this measure is 9 to 79 years. The CAD assesses depressive symptomology in six
diagnostic categories: Negative Affect, Irritability/Agitation, Interest in Pleasure, Positive Affect,
Energy, and Cognitive Efficiency. Items in these categories were developed using wording and
content appropriate for all ages.
In scoring the CAD, item scores are computed into an overall T-score. The CAD does not
specify a specific cutoff score; rather, clinicians are suggested to use a cutoff T-score that they
are comfortable in using. However, qualitative risk categories of T-scores are indicated as the
following: 50 = Normal range, 60-69 = Mild Clinical Risk range, 70-79 = Significant Clinical
Risk range, >79 = Very Significant Clinical Risk range (B. Bracken, personal communication,
March 23, 2004). For this study, a cutoff T-score of 60 was used.
Because the CAD is currently under development, there are limited psychometric data
available at this time. Among age, race, and gender, the CAD reliability analyses have varied
slightly with the Total Scale score range of alpha coefficients being .96 to .98 across subsamples.
The reliability of the subscales on the CAD vary slightly by subsamples: Depressed Mood = .95
to .97, Anxiety/Worry = .82 to .90, Diminished Interest = .79 to .92, Cognitive and Physical
Fatigue = .79 to .91. The CAD Total Scale score test-retest reliability has been found to be .81 to
.87. For the CAD subscales, strong confirmatory factor analysis support has been found.
Concurrent validity was evidenced in correlations between the CAD and the BDI-II total scores
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with ages 8-18 evidencing a correlation of r = .71 and individuals above 18 years evidencing a
correlation of r = .87 (B. Bracken, personal communication, March 23, 2004).
Procedure
The Human Subjects Review Board of Western Kentucky University reviewed and
approved the procedures of this study (see Appendix A). The subjects for the clinical group were
recruited through inpatient and outpatient facilities, as well as private practice clinicians. Once
permission was obtained to solicit participants from these treatment providers, the treatment
providers were given packets and directions for distributing forms (see Appendix B) to
parents/guardians. Treatment providers were also given local fast food restaurant coupons (not
exceeding a $2.00 value) to distribute to each participant upon completion of a packet.
Treatment providers distributed the packets to the parent/guardian. Each packet
contained a letter including the description of the study and an invitation to participate, a parent
consent form, a release of information form, an adolescent assent form, an instruction sheet, and
the CAD and BDI-II depression measures (see Appendix B). To expedite data collection, the
conductor of this study combined data collection with another researcher; therefore, the
Reynolds Adolescent Depression Scale (RADS), was an additional measure included in the
packets. The RADS was not used for the current study.
The instruction sheet found within each packet asked the parent/guardian to complete the
consent form and the release of information form. The adolescents were asked to complete the
assent form and the three depression measures. Upon completion of the three depression
measures and the consent and assent forms, participants were asked to place and seal the
measures in one envelope and the consent and assent forms in the separate envelope provided.
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The parent/guardian and/or participant were instructed to return both packets to their
treatment provider. The conductor of this study retrieved the packets from the providers. The
conductor of this study then asked the treatment providers to complete the Clinician’s Record
Form after a signed release form was obtained from the parent/guardian (see Appendix B).
Subjects comprising the non-referred group were solicited from a local high school in
south-central Kentucky. For data collection at the high school, an introductory letter and consent
form (see Appendix C) was sent home with randomly selected 9th, 10th, 11th, and 12th grade
classrooms. Students who returned forms to school received a local fast food restaurant coupon
that did not exceed a value of $2.00. A coupon was given for returning the consent form whether
or not consent was granted. The students for whom parental consent was obtained were asked to
sign an assent form and complete three measures during school hours. An appropriate time for
completion of questionnaires, which was approximately 25 minutes, was determined between the
researcher and the students’ teachers. A coding system was used so that a student could be
identified in the event of significant responses indicating depression or suicidal ideation.
Parent/guardians were notified by the researcher when significant scores for depression were
found in this group. Names were kept separate from all forms, with no names appearing on the
forms.

Results
The current study had two primary purposes: (a) to examine the strength of the
relationship between the CAD and the BDI-II, and (b) to determine whether group
differences existed between the clinical and non-referred group on the CAD and BDI- II.
Additionally, the hit rate or classification efficacy of the CAD was examined using the BDI-II as
the criterion measure. Table 1 provides the means and standard deviations of the raw scores for
each measure broken down by group and gender.
To examine the relationship between the BDI-II and CAD, correlation coefficients were
computed between the total score on the BDI-II and total score and each subscale of the CAD
(Depressed Mood, Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue).
Using the Bonferroni approach to control for Type I error across the 15 correlations, a p value of
less than .003 was established for significance. The results of the correlational analyses are
presented in Table 2. All correlations were statistically significant and large using Cohen’s
(1988) effect sizes. The results indicate strong concurrent validity between the total score on the
BDI-II and the total score on the CAD, as well as between the BDI-II and each subscale of the
CAD.
To determine whether group differences existed between the clinical and non-referred
groups, independent sample t tests were computed to see if each measure (BDI and CAD)
evidenced mean score differences between the two groups (clinical and non-referred).
Levene’s Test for the Equality of Variances was computed due to the unequal number of
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Table 1
Sample Descriptive Statistics for the Raw Scores on the BDI-IIa and the CADb

BDI-II
Sample

N

M

CAD
SD

SEM

N

M

SD

SEM

8.50 1.27

47

97.34 29.81 4.35

Non-referred
Male

52

9.80

Female

46

15.22 12.59 1.76

52

107.12 29.29 4.06

Total

98

12.68 11.15 1.14

99

102.47 29.80 2.99

Male

10

12.90

9.20 2.91

10

106.40 26.07 8.25

Female

13

25.15 13.67 3.79

13

138.77 27.33 7.58

Total

23

19.83 13.23 2.76

23

124.70 30.90 6.44

Male

62

11.35 16.43 2.20

57

101.87 29.18 3.86

Female

59

20.19 19.27 2.40

65

122.95 31.4

Total

121

16.26 18.94 1.72

122

106.66 31.12 2.82

Clinical

Total Sample

3.90

Note. Clinical sample consisted of individuals diagnosed with Major Depressive Disorder,
Dysthymia, or Depressive Disorder, NOS.
a

Beck Depression Inventory – Second Edition. bClinical Assessment of Depression.
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Table 2
Correlations of BDI-IIa total score with CADSb total score and Scales
1

2

3

4

5

6

1. CAD Total Score

-

.97*

.93*

.90*

.86*

.77*

2. CAD, Depressed Mood

-

-

.86*

.84*

.76*

.75*

3. CAD, Anxiety/Worry

-

-

-

.78*

.78*

.74*

4. CAD, Diminished Interest

-

-

-

-

.77*

.64*

5. CAD, Cognitive & Physical Fatigue

-

-

-

-

-

.66*

6. BDI-II Total Score

-

-

-

-

-

-

Subscale

a

Beck Depression Inventory – Second Edition. bClinical Assessment of Depression.

* p < .004
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participants in the groups. All significance levels were found to be above .05, indicating no
violation of the assumption of homogeniety of variance. Therefore the t tests were interpretable.
The t tests were significant, t (117) = -2.66, p =.009 for the BDI-II, and t (120) = -3.2, p =.002
for the CAD. The results support the hypothesis that the clinical group will evidence higher mean
scores on each of the two measures than the non-referred group. Participants in the clinical group
displayed higher mean scores on both measures than participants in the non-referred group.
Classification efficacy of the CAD was examined using the BDI-II as the criterion
measure. According to Bracken (personal communication, March 23, 2004), a cutoff T-score of
60 is recommended for distinguishing between depressed and non-depressed individuals. Using
the BDI-II cutoff score of 17 and comparing CAD categories of depression (T > 60) and nondepressed to actual BDI-II findings, a 2 X 2 contingency table was computed (Table 3) for the
total sample. The distribution of the score classification between the BDI-II cutoff score and the
CAD cutoff score were found to be significant, Χ2 = 44.72, (p < .000), indicating cell proportions
found are not a chance occurrence. Cell proportions indicated that 82% of the total sample was
correctly identified by the CAD when using the BDI-II as its criterion measure (see Table 3).
Additional contingency tables were computed in order to understand the classification
efficacy of the CAD and BDI-II using group membership (clinical and non-referred) as the
criterion. Table 4 shows a contingency table for the CAD and group membership. The hit rate for
the CAD was found to be 68%. There were 25% false positives and 7% false negatives. The
distribution within the contingency table was significant (Χ2 = 44.72, p < .000) indicating that
this was not a chance occurrence. Table 5 shows a contingency table for the BDI-II and group
membership. The hit rate for the BDI-II was found to be 68%. There were 24% false positives
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Table 3
Total Sample Classification Table between BDI-IIa and CADb Diagnosis of Depression
______________________________________________________________________________
CAD Classification
BDI-II Classification

Non-depressed

Depressed

Total

Non-depressed

56%

10%

66%

(n=68)

(n=12)

(n=80)

8%

26%

34%

(n=10)

(n=32)

(n=42)

64%

36%

100%

(n=78)

(n=44)

Depressed

Total

(n=121)

______________________________________________________________________________
Note. Χ2 = 44.72, p < .000.
a

Beck Depression Inventory – Second Edition; depression classification based on raw score > 17.

b

Clinical Assessment of Depression; depression classification based on T-scores > 60.
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Table 4
Classification Table between CADa Diagnosis of Depression and Group Membershipb

CAD Classification
__________________________________
Group Membership

Non-Referred

Clinical

Total

Non-Significant

Depressed

Total

57%

25%

81%

(n=69)

(n=30)

(n=99)

7.4%

11.5%

19%

(n=9)

(n=14)

(n=23)

64%

36%

100%

(n=78)

(n=44)

(n=122)

___________________________________________________________________________________________________________________

Note. Χ2 = 44.72, p < .000.
a

Clinical Assessment of Depression; depression classification based on T-score > 60.

b

Non-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23

individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder,
Dysthymia, or Depressive Disorder, NOS.
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Table 5
Classification Table between BDI-IIa Diagnosis of Depression and Group Membershipb

BDI-II Classification
___________________________
Group Membership

Non-Significant

Depressed

Total

Non-Referred

66%

15%

81%

(n=81)

(n=18)

(n=99)

12.3%

6.6%

19%

(n=15)

(n=8)

(n=23)

66%

34%

100%

(n=80)

(n=42)

(n=122)

Clinical

Total

______________________________________________________________________________
Note. Χ2 = 44.72, p < .000.
a

Beck Depression Inventory, Second Edition; depression classification based on raw score > 16.

b

Non-referred consisted of 99 adolescents 13-18 years of age; clinical sample consisted of 23

individuals, 13-18 years of age, diagnosed primarily with Major Depressive Disorder,
Dysthymia, or Depressive Disorder, NOS.
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and 8% false negatives. The distribution within the contingency table was significant (Χ2 =
44.72, p < .000) indicating that this distribution was not a chance occurrence.
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Discussion
The purpose of the current study was to determine the strength of the relationship
between the BDI-II and the CAD. High correlations between the two measures were expected.
The second purpose was to examine whether the CAD could discriminate between the clinical
and non-referred participant groups. The clinical group participants were expected to have
significantly higher total scores on the CAD than the non-referred participants. Additionally, the
hit rate or classification efficacy between the CAD and BDI-II was examined.
In determining the strength of the relationship between the CAD and BDI-II, some
noteworthy results were found. Significant, strong correlation coefficients were found between
the total BDI-II score and the total score and each subscale of the CAD (Depressed Mood,
Anxiety/Worry, Diminished Interest, and Cognitive and Physical Fatigue). The strongest
correlation (.97) was between the CAD total score and the CAD Depressed Mood subscale and
the weakest correlation (.66) was between the BDI-II total score and the CAD Cognitive and
Physical Fatigue scale. The correlations obtained account for 75%-94% of the variance on the
two measures. The findings support the hypothesis that the CAD will evidence strong concurrent
validity with the BDI-II.
The second purpose was to establish whether the CAD can discriminate between clinical
and non-referred populations on the basis of group mean scores. Independent samples t tests
were computed to determine if there were mean differences for the two groups (clinical and nonreferred) on the two measures (CAD and BDI-II). The t test for the BDI-II indicated that the two
populations can be discriminated on the basis of group mean scores. The t test for the CAD was
also significant indicating that the clinical group could be distinguished from the non-referred
group on the basis of mean group scores on this measure. For both measures, higher mean

26
scores were found for the clinical groups than for the non-referred group. These findings support
the hypothesis that the clinical group will evidence higher mean scores than the non-referred
group.
The third purpose was to examine the hit rate or classification efficacy, using the BDI-II
as the criterion measure. A Chi square procedure was used and a 2 X 2 contingency table was
computed. From the analyses, 10% of the sample was categorized as false positives on the CAD.
Individuals classified as depressed on the CAD were non-depressed on the BDI-II (the criterion).
False negatives were also determined. Individuals classified as non-depressed on the CAD were
found to be depressed on the BDI-II. Eight percent of the total sample (n = 10) fell within the
false negative category. Considered as the more conservative, false positives are more preferred.
In examining the classification efficacy, a hit rate for the total sample was determined as
high at 82%. However, there were 10% false positives and 8% false negatives. In looking at
group membership, a hit rate of 68% was found for the CAD and BDI-II. With the CAD, there
were 25% false positives and 7% false negatives found. On the BDI-II, there were 24% false
positives found and 8% false negatives found. In the event that the two measures are not
perfectly correlated, it would be expected to find some classification differences between the
measures.
There are also three other possible explanations for the classification differences found.
One explanation could be the small sample size of clinical group participants (n=23) when
compared to the non-referred group participants (n=98). A higher hit rate found with the nonreferred group may be because of the larger sample size. A second explanation is that more
clinical group participants were from outpatient facilities than from inpatient facilities. As such,
it would appear that the clinical sample consisted of less severely depressed individuals. A third
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explanation could be the uncertainty of the clinical participants status on the continuum of
depression. The researcher was unaware of how long each participant had been diagnosed with
depression and had been receiving treatment.
Limitations
Before findings of the current study can be interpreted and generalized, limitations of the
study need to be considered. The small sample size, limited geographic area, and small
percentage of ethnicities represented among the participants of the clinical and non-referred
groups may have limited the amount of information gathered and the generalizability of the data
obtained. Also, the recruitment of clinical participants from both inpatient and outpatient
facilities may explain some of the classification discrepancies between the measures (hit rate).
For the current study, it is difficult to know if any events occurred prior to completion of
the two measures that may have impacted the responses of the participants and threatened
internal validity (e.g., relationship difficulties, school stress). An additional threat to internal
validity is that the non-referred group was self-reported to have no existing diagnosis of
depression. It is possible that some participants of this group did in fact have a diagnosis of
depression. Based on the ratings on the two measures (BDI-II and CAD), 21 individuals in the
non-referred group had clinically significant levels of depression.
A threat to external validity of the study is noted, in that the clinical sample relied on
treatment providers to recruit clinical participants to ensure confidentiality. Individuals
diagnosed with depression and not seeking treatment were not included in this study. Another
threat to external validity is that the clinical sample was not homogeneous. Some participants
had secondary diagnoses and one participant had depression as the secondary diagnosis. In
addition, the clinical sample represented all diagnoses of depression and not just one particular
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diagnosis such as Major Depression only or Dysthymia only. A more homogeneous sample may
have provided different or more consistent findings.
Other factors impacting the external validity of the study include the extent and method
of treatment the clinical participants were receiving and whether the participants were currently
taking any medications. A final threat to external validity is that the data for this study were
collected in one geographic location (south-central Kentucky). Although the clinical and nonreferred sample was relatively balanced for gender and representative of the ethnicity of the
region, 7% minority, generalizability to other geographic regions may not be valid.
Implications
Practical implications. The major implication of the current study is that psychometric
evidence has been established and provided for the CAD’s use as a measure for assessing
depression in adolescents. The hit rate or classification efficacy when using the BDI-II as a
criterion measure was established as high. The current study has also expanded the knowledge
base of available adolescent depression measures. While depression measures are limited for
children and adolescent populations, it is important that additional measures be established, in
addition to the CAD and BDI-II. With prevalence rates of childhood depression on the rise, and
the high need for professionals to utilize depression measures (Camara et al., 2000), it is
imperative that valid and reliable measures be established and made accessible. Measures that
can adequately identify and diagnosis depressive symptoms will increase the likelihood of
accurate treatment.
Further research. In regard to future research, the psychometric properties of the CAD
warrant further investigation. Additional studies addressing differing age groups, different
clinical groups (outpatient versus inpatient), and more homogeneous diagnoses may help to
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further clarify the usefulness of the CAD. Future research should also investigate the subscales
of the CAD with other established measures that measure wider ranges of symptomology,
including depression, such as rating scales that assess both internalizing and externalizing
behaviors. In addition, future studies should expand sample size and the geographic area to
enhance the generalizablity of findings. Evidence of validity should also be obtained through
factor analytic procedures to substantiate the subscale structure of the CAD.
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WESTERN KENTUCKY UNIVERSITY
Human Subjects Review Board
Office of Sponsored Programs
104 Foundation Building
270-745-4652; Fax 270-745-4211
E-mail: Phillip.Myers@Wku.Edu
In future correspondence please refer to HS03-077, April 3, 2003
Shanna Bowers
1500 Crossbreeze Ct.
Bowling Green, KY 42104
Dear Shanna:
Your research project, "Concurrent Validity of Adolescent Depression Measures," was reviewed
by the HSRB and it has been determined that risks to subjects are: (1) minimized and reasonable;
and that (2) research procedures are consistent with a sound research design and do not expose
the subjects to unnecessary risk. Reviewers determined that: (1) benefits to subjects are
considered along with the importance of the topic and that outcomes are reasonable; (2) selection
of subjects is equitable; and (3) the purposes of the research and the research setting is amenable
to subjects' welfare and producing desired outcomes; that indications of coercion or prejudice are
absent, and that participation is clearly voluntary.
1. In addition, the IRB found that: (1) signed informed consent will be obtained from all
subjects. (2) Provision is made for collecting, using and storing data in a manner that protects
the safety and privacy of the subjects and the confidentiality of the data. (3) Appropriate
safeguards are included to protect the rights and welfare of the subjects. (4) Any ad or flyer
used to recruit participants must be reviewed by the HSRB before used.
a. Your research therefore meets the criteria of Full Board Review and is Approved.
2. Please note that the institution is not responsible for any actions regarding this protocol before
approval. If you expand the project at a later date to use other instruments please re-apply.
Copies of your request for human subjects review, your application, and this approval, are
maintained in the Office of Sponsored Programs at the above address. Please report any changes
to this approved protocol to this office. A Continuing Review protocol will be sent to you in the
future to determine the status of the project.
Sincerely,
Phillip E. Myers, Ph.D.
Director, OSP and
Human Protections Administrator
cc: Human Subjects File HS03-077
cc: Shanna Bowers
cc: Dr. Elizabeth Jones
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Dear Parent/Guardian,
Your child is invited to participate in a study looking at the usefulness of 3 measures of social and
emotional well-being. This study is being conducted by Shanna Bowers, Brooke Wootton and Dr.
Elizabeth Jones of Western Kentucky University in cooperation with your child’s clinician. The
results of the study will be used to determine how well these 3 instruments measure social and
emotional well-being in adolescents.
In addition, the data from this study will be used to evaluate a new instrument that measures social
and emotional well-being. Such data can provide information about the new instruments’ usefulness
and ability to measure what it sets out to measure. If you agree to allow your child’s responses to be
used in this evaluation process, there is a separate consent form included in this packet that requires
your signature. This form will be returned to the test publisher.
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning. It
will take approximately 25 minutes to complete and this may be done before or after your child’s
therapy sessions. You will also be asked to complete a release of information form to allow your
child’s therapist to release diagnosis, medication, and family history information. This information
will only be used by the researchers to insure that research requirements are met. Your child’s name
will not appear on this form. For your child’s participation in this study he or she will receive a local
fast food restaurant coupon that will not exceed a $2.00 value.
Your consent and your child’s participation are completely voluntary. At any time withdrawal from
the study is possible. If you do not consent for your child to participate, it will have no negative
outcomes for you or your child and will not affect the relationship with the clinician. There are no
physical risks involved in filling out the questionnaires. However, answering the items on the
questionnaires may cause your child to feel some emotional discomfort, due to the nature of the
questions asked about your child’s behavior. All information collected in this study will be kept
strictly confidential and will be accessible only to project staff. However, all packets will be coded
to allow for identification only if an individual's responses indicate a threat to self or others on the
questionnaires. Researchers must by law report this information to your child’s clinician and you
will be immediately informed.
The procedures in this study have been reviewed and approved by the Western Kentucky University
Human Subjects Review Board. If you have questions about the study you may contact Dr. Elizabeth
Jones by phone at (270) 745-4414. We hope that both you and your child agree to take part in our study.
To indicate your consent for participation please complete and sign the attached form, have your child
complete the questionnaires, and return the packet to your child’s clinician.
Sincerely,

Elizabeth L. Jones
Associate Professor of Psychology

Shanna Bowers
Brooke Wootton
School Psychology Graduate Students
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Participation Consent Form
Child’s Age ____

Child’s Gender __ M __F

Child’s Race/Ethnicity________

I have read the information provided concerning this study. I give consent for my child to
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones
of Western Kentucky University. I understand that I may withdraw from the study at any time
without penalty.
_____ I DO give consent for my child to participate in this study.
_____ I DO NOT give consent for my child to participate in this study.
Parent/Guardian Signature ______________________________

Date __________
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PARENT/GUARDIAN CONSENT FORM

Research Participation in a Behavioral Study
General Information and Purpose

My child:____________________ has been asked to participate in a research study
being conducted by PAR, Inc., a developer and publisher of educational and behavioral
assessment tools. The purpose of the study is to evaluate a new test designed to
identify behavioral problems in adolescents. I have been asked to participate in this
study because I am the parent of a child (ages 2 to 18 years); if my child is between 8
and 18-years-old, he or she has also been asked to participate.
What is involved in my child’s participation?

If I agree (and give consent for my child) to participate in this study, my child will
complete one or more questionnaires that ask about my child’s academic, social, and
personal behaviors. Children questionnaires take from 15 to 30 minutes to complete.
Risks

There is no physical risk involved in filling out the questionnaires. Answering the
questions on the questionnaires may cause my child to feel some emotional discomfort,
due to the nature of the questions asked about my child’s behavior.
Benefits

The results of this study may be of benefit in the future to children with behavioral
problems and the professionals who evaluate and treat them. There is no immediate
benefit to my child for their participation, however they may benefit in the event
that they indicate suicide or harm to others. If such indicators are present, they
will be identified and I will be identified immediately.
Confidentiality

My child’s answers on the questionnaires are strictly confidential and
anonymous. I will not be asked to put my child’s name on the questionnaires.
Only the primary researchers or their designees will have access to my child’s
confidential survey responses. However, the packets will be coded to allow for
identification only if my child’s responses indicate suicide or harm to others. By
law researchers must report this information to you immediately.
Right to Withdraw or Decline to Participate

My child’s participation in this study is completely voluntary. He/she may choose not to
participate, or to withdraw from participation at any time without penalty.
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I attest that I have read and understand all of the above pertaining to my child’s
participation in this study, and that all of my questions about the study have been
answered to my satisfaction. I hereby give my informed consent for my child to
participate in this research study.
____________________________ ____________________________
Parent’s Name (please print)
Parent’s Signature

Date

If you have any questions regarding this research study or participation in it, please call Michelle Owens or Dr. Mario Rodriguez (Project Director) at 1-866-PARDATA or 1-800-331-TEST. PAR, Inc./16204 N. Florida Avenue, Lutz FL 33549/Tel (813)968-3003/Fax (813)968-4684
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Release of Information
CONCURRENT VALIDITY STUDY OF ADOLESCENT DEPRESSION MEASURES

(1) TO:_______________________________

(2) DATE:__________________

_______________________________
_______________________________
(3) RE:___________________________
Name
___________________________
Address
Authorization is hereby granted to release to Western Kentucky University (WKU) researchers:
Dr. Elizabeth Jones, Shanna Bowers, and Brooke Wootton, and Psychological Assessment
Resources (PAR) researchers such information relative to service rendered.
(4) ___________________________
Signature of Parent
___________________________
Address
___________________________

(5) ____________________________
Witness

___________________________
Date

Information particularly requested is listed below:
Your Childs: Age
Gender
Race
Primary DSM-IV Diagnosis
List of Current Medications
Family History of DSM-IV Diagnosis
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As mentioned before, the purpose of this study is to use self-report measures to identify social
and emotional well-being in adolescents. To ensure that the participants of this study meet
diagnosis criteria, it is necessary to obtain diagnosis information from a clinician.
Attached is a release form that must be completed so that your child’s therapist can release
diagnosis and medication information to the researchers.
•

Fill in the name of your child’s therapist at #1

•

Put today’s date at #2

•

Put your child’s name at #3

•

Sign your name, provide address and date at #4

•

Have a witness (someone over 18 years of age) sign at #5
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Participation Assent Form
I have read and understand the information provided about this study. I give assent to participate
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western
Kentucky University. I understand that I may withdraw from this study at any time without
penalty.
I, ________________________, understand that my parent/guardian has given permission for
me to participate in a study concerning social and emotional well-being, under the direction of
Western Kentucky University.
My participation in this project is completely voluntary, and I understand that I may stop my
participation in this study at any time. I am aware that I am encouraged to answer all of the
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items. If
I choose not to participate, it will not affect my treatment in any way.
Signature _________________________

Date____________
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Bracken
Project

Survey

Clinician Record Form
Date: ________________

Clinician Name:_____________________________________
Age:______

Please provide the following information for the individual participant being rated/tested.
Gender: ______ Race/Ethnicity: ____________
ID No.: _____________________
Primary DSM-IV Diagnosis(es): _____________________________________________________
Estimated Date of Dx: ______________
Diagnosis made by:

1) ________________
Secondary
DSM-IV
Diagnoses:

Psychologist

Psychiatrist

Pediatrician

Primary care physician

School Personnel

Other: _______________

Estimated Date of Dx: ______

Current?
Yes No

2) ________________

Estimated Date of Dx:_______ Yes No

3) ________________

Estimated Date of Dx: _______ Yes No

Current Psychotropic Medications:

1) ___________________________________________
2) ___________________________________________
3) ___________________________________________

Does either parent or any sibling carry a DSM-IV diagnosis(es)?
If yes, indicate biological relative(s) and respective diagnosis(es):

No

Yes

Appendix C

Non-referred Packet Forms
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Dear Parent/Guardian,
Your child is invited to participate in a study looking at the usefulness of 3 measures of social
and emotional well-being used with adolescents. This study is being conducted by Shanna
Bowers, Brooke Wootton and Dr. Elizabeth Jones of Western Kentucky University. The results
of the study will be used to determine how well these 3 instruments measure social and
emotional well-being in adolescents.
In addition, the results of this study will be used to evaluate a new instrument that measures
social and emotional well-being. Such data can provide information about the new instrument’s
usefulness and ability to measure what it sets out to measure. If you agree to allow your child’s
responses to be used in this evaluation process, there is a separate consent form included in this
packet that requires your signature. This form will be returned to the test publisher.
Upon your consent and your child’s assent, your child will be asked to complete 3 questionnaires
concerning their thoughts, feelings, and emotions as they relate to their day-to-day functioning.
It will take approximately 25 minutes to complete the three questionnaires.
For your child’s participation in this study he or she will receive a local fast food restaurant
coupon that will not exceed a $2.00 value.
Your consent and your child’s participation are completely voluntary. At any time withdrawal
from the study is possible. If you do not consent for your child to participate, it will have no
negative outcomes for you or your child. There are no physical risks involved in filling out the
questionnaires. However, answering the items on the questionnaires may cause your child to feel
some emotional discomfort, due to the nature of the questions asked about your child’s behavior.
All information collected in this study will be kept strictly confidential and will be accessible
only to the project staff. However, all packets will be coded to allow for identification only if an
individual's responses indicate a threat to self or others on the questionnaires. Researchers must
by law report this information to you immediately.
The procedures in this study have been reviewed and approved by the Western Kentucky
University Human Subjects Review Board. If you have questions about the study you may
contact Dr. Elizabeth Jones by phone at (270) 745-4414. We hope that both you and your child
agree to take part in our study. To indicate your consent for participation please complete and
sign the attached form.
Sincerely,
Elizabeth L. Jones
Associate Professor of Psychology

Shanna Bowers
Brooke Wootton
School Psychology Graduate Students
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Participation Consent Form
Child’s Age ____

Child’s Gender __ M __F

Child’s Race/Ethnicity________

I have read the information provided concerning this study. I give consent for my child to
participate in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones
of Western Kentucky University. I understand that I may withdraw from the study at any time
without penalty.
_____ I DO give consent for my child to participate in this study.
_____ I DO NOT give consent for my child to participate in this study.
Parent/Guardian Signature_______________________________ Date __________
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Participation Assent Form
I have read and understand the information provided about this study. I give assent to participate
in this study conducted by Shanna Bowers, Brooke Wootton, and Dr. Elizabeth Jones of Western
Kentucky University. I understand that I may withdraw from this study at any time without
penalty.
I, ________________________, understand that my parent/guardian has given permission for
me to participate in a study concerning social and emotional well-being, under the direction of
Western Kentucky University.
My participation in this project is completely voluntary, and I understand that I may stop my
participation in this study at any time. I am aware that I am encouraged to answer all of the
items, even if I am unsure how to respond, and that I hold the right to refuse to answer items.
Whether or not I choose to participate, I will not be affected in any way.
Signature _________________________

Date____________

